Ameriprise’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $748M | Buy |
|
|||||
|
2025
Q1 | $152M | Buy |
|
|||||
|
2024
Q4 | $123M | Sell |
|
|||||
|
2024
Q3 | $159M | Sell |
|
|||||
|
2024
Q2 | $137M | Buy |
|
|||||
|
2024
Q1 | $119M | Buy |
|
|||||
|
2023
Q4 | $129M | Sell |
|
|||||
|
2023
Q3 | $128M | Buy |
|
|||||
|
2023
Q2 | $122M | Sell |
|
|||||
|
2023
Q1 | $139M | Buy |
|
|||||
|
2022
Q4 | $127M | Sell |
|
|||||
|
2022
Q3 | $100M | Sell |
|
|||||
|
2022
Q2 | $102M | Sell |
|
|||||
|
2022
Q1 | $105M | Buy |
|
|||||
|
2021
Q4 | $102M | Buy |
|
|||||
|
2021
Q3 | $83.8M | Sell |
|
|||||
|
2021
Q2 | $261M | Sell |
|
|||||
|
2021
Q1 | $255M | Sell |
|
|||||
|
2020
Q4 | $268M | Sell |
|
|||||
|
2020
Q3 | $291M | Buy |
|
|||||
|
2020
Q2 | $346M | Sell |
|
|||||
|
2020
Q1 | $468M | Sell |
|
|||||
|
2019
Q4 | $466M | Sell |
|
|||||
|
2019
Q3 | $466M | Sell |
|
|||||
|
2019
Q2 | $547M | Buy |
|
|||||
|
2019
Q1 | $493M | Buy |
|
|||||
|
2018
Q4 | $474M | Buy |
|
|||||
|
2018
Q3 | $487M | Sell |
|
|||||
|
2018
Q2 | $445M | Buy |
|
|||||
|
2018
Q1 | $399M | Buy |
|
|||||
|
2017
Q4 | $368M | Sell |
|
|||||
|
2017
Q3 | $446M | Buy |
|
|||||
|
2017
Q2 | $211M | Sell |
|
|||||
|
2017
Q1 | $248M | Buy |
|
|||||
|
2016
Q4 | $202M | Buy |
|
|||||
|
2016
Q3 | $195M | Sell |
|
|||||
|
2016
Q2 | $326M | Sell |
|
|||||
|
2016
Q1 | $400M | Sell |
|
|||||
|
2015
Q4 | $550M | Sell |
|
|||||
|
2015
Q3 | $688M | Sell |
|
|||||
|
2015
Q2 | $895M | Sell |
|
|||||
|
2015
Q1 | $848M | Sell |
|
|||||
|
2014
Q4 | $845M | Sell |
|
|||||
|
2014
Q3 | $1.52B | Sell |
|
|||||
|
2014
Q2 | $1.49B | Sell |
|
|||||
|
2014
Q1 | $1.33B | Sell |
|
|||||
|
2013
Q4 | $1.51B | Sell |
|
|||||
|
2013
Q3 | $1.36B | Sell |
|
|||||
|
2013
Q2 | $1.12B | Buy |
|